| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/12/2007 | CN100336509C Aripiprazole orally disintegrating tablet formulation and its preparing method |
| 09/11/2007 | US7268213 Glucagon-like peptide-1 (glp-1) receptor agonist |
| 09/11/2007 | US7268164 Administering an amino carbonyl compound |
| 09/11/2007 | US7268160 A therapeutic or prophylactic agent for a disease that requires enhancement of nerve growth factor production, e.g., butein; nervous system disorders; Alzeimher's disease; additive for foods, beverages and feeds |
| 09/11/2007 | US7268152 Antiinflammatory agents; antiallergens; antiproliferative agents |
| 09/11/2007 | US7268146 (3,4-Dihydro-1H-isoquinolin-2-yl)-[2-methyl-7-(2,4,6-trimethyl-phenyl)-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-b]pyridin-3-yl]-methanone; Corticotropin releasing factor (CRF); stress-related illnesses, mood disorders such as depression, major depressive disorder, single episode depression |
| 09/11/2007 | US7268133 Cannabinoid receptor ligands and uses thereof |
| 09/11/2007 | US7268132 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder |
| 09/11/2007 | US7268130 Benzothiadiazine compounds |
| 09/11/2007 | US7268129 Fluorinated benzothiadiazine compounds |
| 09/11/2007 | US7268128 Increase the intracellular cAMP level and further inhibit the activation of T cells; allergic diseases, inflammatory or immunological diseases |
| 09/11/2007 | US7268127 Azaindoles having serotonin receptor affinity |
| 09/11/2007 | US7268125 2-(azetidin-2-on-1-yl)alkanedioic acid esters and amides useful for treating disease states that are associated with and responsive to antagonism of a vasopressin V1a receptor in a mammal |
| 09/11/2007 | US7268123 Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and methods of making them |
| 09/11/2007 | US7268109 Method for reducing pain |
| 09/11/2007 | US7267827 For therapy of inflammatory and pain of a traumatic or pathologic origin |
| 09/11/2007 | US7267813 Inhalation particles incorporating a combination of two or more active ingredients |
| 09/11/2007 | CA2429114C Treatment of premature ejaculation |
| 09/11/2007 | CA2397262C Use of central cannabinoid receptor antagonist for preparing medicines designed to facilitate smoking cessation |
| 09/11/2007 | CA2231975C Substituted amino compounds and their use as substances having an analgesic effect |
| 09/11/2007 | CA2193967C Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
| 09/11/2007 | CA2176935C Indole-derived azylpiperazines as ligands for 5ht1-like receptors 5ht1b and 5ht1d |
| 09/09/2007 | CA2638622A1 Peripheral and neural inflammatory crosstalk |
| 09/07/2007 | WO2007100880A1 Cinnoline and quinazoline derivates as phosphodiesterase 10 inhibitors |
| 09/07/2007 | WO2007100852A1 Therapeutic piperazines as pde4 inhibitors |
| 09/07/2007 | WO2007100851A1 Therapeutic compounds |
| 09/07/2007 | WO2007100755A1 Method for decreasing the toxic effects of nicotine on fetuses in pregnant women |
| 09/07/2007 | WO2007100670A1 Spiro condensed piperidnes as modulators of muscarinic receptors |
| 09/07/2007 | WO2007100566A2 Use of dha and ara in the preparation of a composition for regulating gene expression |
| 09/07/2007 | WO2007100536A1 DIHYDROSPIRO[DIBENZO[A,D][7]ANNULENE-5,4'-IMIDAZOL] COMPOUNDS FOR THE INHIBITION OF β-SECRETASE |
| 09/07/2007 | WO2007100282A1 New salts of an indole derivative and their use in medicine |
| 09/07/2007 | WO2007099999A1 Novel glycolipid and use thereof |
| 09/07/2007 | WO2007099828A1 Nirogenous heterocyclic derivatives substituted with cyclic groups |
| 09/07/2007 | WO2007099423A1 1-pyrrolidine indane derivatives as histamine-3 receptor antagonists |
| 09/07/2007 | WO2007099227A2 Use of the engrailed homeodomain protein as an anxiolytic |
| 09/07/2007 | WO2007099166A1 Pyrazolo-pyridine derivatives active as kinase inhibitors |
| 09/07/2007 | WO2007099162A2 Hydroxylated long-chain resveratrol derivatives useful as neurotrophic agents |
| 09/07/2007 | WO2007099151A1 Methods and agents for reducing oxidative stress |
| 09/07/2007 | WO2007098967A2 Imidazole compounds having pharmaceutical activity towards the sigma receptor |
| 09/07/2007 | WO2007098963A1 Sigma receptor inhibitors |
| 09/07/2007 | WO2007098962A1 Sigma receptor compounds |
| 09/07/2007 | WO2007098953A1 Pyrazole derivatives as sigma receptor inhibitors |
| 09/07/2007 | WO2007098860A1 New morphine compounds for pharmaceutical compositions |
| 09/07/2007 | WO2007098607A1 Methods and compositions to treat and detect misfolded-sod1 mediated diseases |
| 09/07/2007 | WO2007084535A3 Neuronal nicotinic receptor ligands and their use |
| 09/07/2007 | WO2007084290A3 Compositions of an anticonvulsant and psychotherapeutic and methods of using the same for reversing weight gain |
| 09/07/2007 | WO2007082909A3 Method for treating huntington's disease by inhibiting dephosphorylation of huntingtin at s421 |
| 09/07/2007 | WO2007071733A3 Use of dha, epa or dha-derived epa for treating a pathology associated with cellular oxidative damage |
| 09/07/2007 | WO2007068434A3 Medicament based on a monoester of steroids with long chain fatty acids |
| 09/07/2007 | WO2007065713A8 Use of 8-alpha-ergolines for the treatment of traumatic brain disorders |
| 09/07/2007 | WO2007063509A8 Phosphocreatine complexes |
| 09/07/2007 | WO2007060486A3 Treatment of neurodegenerative disorders |
| 09/07/2007 | WO2007060144A3 Novel quinoxaline derivatives and their medical use |
| 09/07/2007 | WO2007052125A3 Solid oral pharmaceutical compositions for once daily dosing containing pregabalin, a matrix forming agent and a swelling agent |
| 09/07/2007 | WO2007031878A3 Methods of treating nervous disorders |
| 09/07/2007 | WO2007011878A3 Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists |
| 09/07/2007 | CA2645123A1 Use of dha and ara in the preparation of a composition for regulating gene expression |
| 09/07/2007 | CA2644570A1 Hydroxylated long-chain resveratrol derivatives useful as neurotrophic agents |
| 09/07/2007 | CA2644069A1 Therapeutic piperazines as pde4 inhibitors |
| 09/07/2007 | CA2644068A1 Therapeutic compounds |
| 09/07/2007 | CA2643723A1 Cathepsin propeptide and uses thereof |
| 09/07/2007 | CA2643722A1 Use of the engrailed homeodomain protein as an anxiolytic |
| 09/07/2007 | CA2643320A1 Modulators of muscarinic receptors |
| 09/07/2007 | CA2643044A1 Cinnoline and quinazoline derivates as phosphodiesterase 10 inhibitors |
| 09/07/2007 | CA2642848A1 Methods and compositions to treat and detect misfolded-sod1 mediated diseases |
| 09/07/2007 | CA2642649A1 Modulators of muscarinic receptors |
| 09/07/2007 | CA2641513A1 Methods of treating inflammatory and autoimmune diseases with natalizumab |
| 09/07/2007 | CA2641145A1 Sigma receptor compounds |
| 09/07/2007 | CA2641144A1 Pyrazole derivatives as sigma receptor inhibitors |
| 09/07/2007 | CA2640757A1 Imidazole compounds having pharmaceutical activity towards the sigma receptor |
| 09/07/2007 | CA2640754A1 Pyrazole derivatives as sigma receptors antagonists |
| 09/07/2007 | CA2640753A1 Sigma receptor inhibitors |
| 09/07/2007 | CA2635280A1 Side chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
| 09/06/2007 | US20070208066 ER-beta-selective ligands |
| 09/06/2007 | US20070208049 e.g. 1-(2,6-Difluorobenzyl)-5-(3-Mehthoxyphenyl)-6-Methyl-3-[N-Methyl -N -(2-Pyridylethyl)Aminoethyl]Uracil; anticarcinoganic agent; prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 09/06/2007 | US20070208048 New Aryl Imidazoles and Related Compounds as C5a Receptor Modulators |
| 09/06/2007 | US20070208046 such as 4-benzyloxy-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1H-pyridin-2-one, that as antagonists to melanin concentrating hormone receptors, used for treating cardiovascular, nervous system, metabolic, reproductive system, respiratory system and gatrointestinal disorders |
| 09/06/2007 | US20070208036 Arylalkanes, arylalkenes and aryl-azaalkanes, pharmaceutical compositions containing these compounds and processes for preparing them |
| 09/06/2007 | US20070208030 Tetrahydroindolone Derivatives for Treament of Neurological Conditions |
| 09/06/2007 | US20070208016 1-(3-tert-butyl-4-methoxy-5-morpholinophenyl)-2-(5,6-diethoxy-7-fluoro-1-imino-1,3-dihydroisoindol-2-yl)ethanone,; stabilizing the composition; not decompose even when placed under humidification conditions |
| 09/06/2007 | US20070208008 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
| 09/06/2007 | US20070208006 For treatment of behavioral disorders associated with dementia, psychoses |
| 09/06/2007 | US20070207957 Composition For Accelerating Alcohol Metabolism Or Relieving Fatigue By Gluconeogenesis |
| 09/06/2007 | US20070207943 Interleukins-21 and 22 |
| 09/06/2007 | US20070207523 Mammalian t-type calcium channels |
| 09/06/2007 | US20070207230 Extract of nelumbinis semen for the treatment of depression, medicinal composite and health foods including the extract of nelumbinis semen |
| 09/06/2007 | US20070207153 Therapeutic Agents For Inner Ear Disorders Containing An Il-6 Antagonist As An Active Ingredient |
| 09/06/2007 | US20070207140 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 09/06/2007 | US20070207134 Functional food for ameliorating engogenous melatonin secretion rhythm and functional food for ameliorating circadian rhythm |
| 09/06/2007 | DE102006008880A1 Aminopyrimidinderivate Aminopyrimidine derivatives |
| 09/05/2007 | EP1829888A1 Anti-inflammatory compounds and uses thereof |
| 09/05/2007 | EP1829878A1 New morphine derivatives and pharmaceutical compositions containing the same |
| 09/05/2007 | EP1829875A1 Pyrazole derivatives as sigma receptor inhibitors |
| 09/05/2007 | EP1829873A1 Pyrrazole derivatives as sigma receptors antagonists |
| 09/05/2007 | EP1829867A1 Imidazole compounds having pharmaceutical activity towards the sigma receptor |
| 09/05/2007 | EP1829866A1 Sigma receptor inhibitors |
| 09/05/2007 | EP1829864A1 Isoquinoline derivatives as calpain inhibitors |
| 09/05/2007 | EP1829862A1 Sigma receptor compounds |
| 09/05/2007 | EP1829582A1 An extractive of piper laetisipicum c.dc., its process and its uses |
| 09/05/2007 | EP1829559A1 Method for improving sleep behaviors |